Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-17

Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567. [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD9567 (AZD9567)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED